The Vietnam newborn screening scheme was officially started in 2007 by The General Office of Population and Family Planing. The objective was to raise community awareness and set up networks of new- born screening service all over the country. Screening tests were not covered by public insurance system; therefore, the scheme paid the screening G6PD deficiency and congenital hypothyroidism for the poor and remote area resi- dents while local governments helped hospitals and health centers socialize the screening for other people.
We would like to recognize the Hospital Nacional Docente Madre Niño San Bartolome as the first newborn screening laboratory in Lima, Peru to join laboratories world-wide using AutoDELFIA® analyzers to screen for TSH and 17 OHP. This laboratory also expects to be the first lab in Peru to meet the government mandate to screen all newborns for Cystic Fibrosis using the IRT assay. Congratulations to Dr. Bindels and her team for making this happen.
PerkinElmer® Genetics, located just outside of Pittsburgh, Pennsylvania, has been providing newborn screening services for over 20 years. During that time, the laboratory has processed close to six million samples using biochemical, molecular and mass spec based technology while partnering with the states of Pennsylvania, Mississippi, Nebraska, Louisiana and the District of Columbia. In 2010, PerkinElmer Genetics started offering a 6-plex assay to test for Gaucher, Niemann-Pick, Krabbe, Hurler-MPS-I, Pompe and Fabry lysosomal storage disorders. More recently, they completed the development and validation of tests for MPS-IVA and VI. Work is also underway to add testing for Adrenoleukodystrophy (X-ALD) with the goal to being able to offer all these tests as part of their StepOne® Newborn Screening, a “Lab in a Lab” or as back-up testing for labs that experience unplanned outages. For more information, please contact PJ Borandi at PJ.Borandi@PerkinElmer.com.
The NBS Program in the Philippines started out as a pilot project involving 24 hospitals in the country’s capital region. It took some time for the newborn screening program to be successfully integrated into the national health program through the Philippine Newborn Screening Act of 2004. Almost two decades after the pilot project, the program was deemed ready for the expansion from screening for six disorders to screening for more than 20 disorders. The presentation from Dr. Melanie presents the challenges of implementing an expanded newborn screening program in a developing country like the Philippines and the conditions identified in the first phases of offering the service.